South Korea · Delayed Price · Currency is KRW Samsung Biologics Statistics
Total Valuation
KRX:207940 has a market cap or net worth of KRW 77.82 trillion. The enterprise value is 77.26 trillion.
| Market Cap | 77.82T |
| Enterprise Value | 77.26T |
Important Dates
The next estimated earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:207940 has 46.29 million shares outstanding. The number of shares has decreased by -5.85% in one year.
| Current Share Class | 46.29M |
| Shares Outstanding | 46.29M |
| Shares Change (YoY) | -5.85% |
| Shares Change (QoQ) | +179.04% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 12.95% |
| Float | 11.83M |
Valuation Ratios
The trailing PE ratio is 69.78 and the forward PE ratio is 44.86. KRX:207940's PEG ratio is 1.45.
| PE Ratio | 69.78 |
| Forward PE | 44.86 |
| PS Ratio | 17.08 |
| PB Ratio | 10.44 |
| P/TBV Ratio | 10.53 |
| P/FCF Ratio | 90.90 |
| P/OCF Ratio | 34.62 |
| PEG Ratio | 1.45 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.13, with an EV/FCF ratio of 90.25.
| EV / Earnings | 43.30 |
| EV / Sales | 16.95 |
| EV / EBITDA | 28.13 |
| EV / EBIT | 36.57 |
| EV / FCF | 90.25 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.74 |
| Quick Ratio | 0.85 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 1.08 |
| Interest Coverage | 70.93 |
Financial Efficiency
Return on equity (ROE) is 17.59% and return on invested capital (ROIC) is 17.20%.
| Return on Equity (ROE) | 17.59% |
| Return on Assets (ROA) | 9.11% |
| Return on Invested Capital (ROIC) | 17.20% |
| Return on Capital Employed (ROCE) | 24.26% |
| Weighted Average Cost of Capital (WACC) | 5.36% |
| Revenue Per Employee | 955.34M |
| Profits Per Employee | 374.08M |
| Employee Count | 4,770 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 0.83 |
Taxes
In the past 12 months, KRX:207940 has paid 504.30 billion in taxes.
| Income Tax | 504.30B |
| Effective Tax Rate | 23.80% |
Stock Price Statistics
The stock price has decreased by -10.54% in the last 52 weeks. The beta is 0.21, so KRX:207940's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -10.54% |
| 50-Day Moving Average | 1,764.00 |
| 200-Day Moving Average | 1,648.00 |
| Relative Strength Index (RSI) | 28.27 |
| Average Volume (20 Days) | 55,447 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:207940 had revenue of KRW 4.56 trillion and earned 1.78 trillion in profits. Earnings per share was 26,628.00.
| Revenue | 4.56T |
| Gross Profit | 2.50T |
| Operating Income | 2.07T |
| Pretax Income | 2.12T |
| Net Income | 1.78T |
| EBITDA | 2.70T |
| EBIT | 2.07T |
| Earnings Per Share (EPS) | 26,628.00 |
Balance Sheet
The company has 1.49 trillion in cash and 927.09 billion in debt, with a net cash position of 557.99 billion or 12,053.95 per share.
| Cash & Cash Equivalents | 1.49T |
| Total Debt | 927.09B |
| Net Cash | 557.99B |
| Net Cash Per Share | 12,053.95 |
| Equity (Book Value) | 7.45T |
| Book Value Per Share | 57,685.15 |
| Working Capital | 1.88T |
Cash Flow
In the last 12 months, operating cash flow was 2.25 trillion and capital expenditures -1,391.74 billion, giving a free cash flow of 856.07 billion.
| Operating Cash Flow | 2.25T |
| Capital Expenditures | -1,391.74B |
| Free Cash Flow | 856.07B |
| FCF Per Share | 18,493.17 |
Margins
Gross margin is 54.88%, with operating and profit margins of 45.41% and 39.16%.
| Gross Margin | 54.88% |
| Operating Margin | 45.41% |
| Pretax Margin | 46.49% |
| Profit Margin | 39.16% |
| EBITDA Margin | 59.31% |
| EBIT Margin | 45.41% |
| FCF Margin | 18.79% |
Dividends & Yields
KRX:207940 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.85% |
| Shareholder Yield | 5.85% |
| Earnings Yield | 2.29% |
| FCF Yield | 1.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 30, 2025. It was a reverse split with a ratio of 0.6503913.
| Last Split Date | Oct 30, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.6503913 |
Scores
KRX:207940 has an Altman Z-Score of 14.63 and a Piotroski F-Score of 8.
| Altman Z-Score | 14.63 |
| Piotroski F-Score | 8 |